This study of percutaneous coronary revascularization in patients with a prior history of diabetes and cardiovascular risk factor control reveals increased mortality only in patients with diabetes mellitus requiring insulin treatment but not in those on diet control or oral hypoglycemic agents. This evidence concerns the gene INS and diabetes mellitus.